SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 155 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $18,750,000 | +70.5% | 1,250,000 | 0.0% | 1.69% | +34.2% |
Q2 2017 | $11,000,000 | +164.2% | 1,250,000 | +39.0% | 1.26% | +193.5% |
Q3 2016 | $4,164,000 | -38.3% | 899,438 | -22.9% | 0.43% | -54.0% |
Q2 2016 | $6,751,000 | -49.6% | 1,165,938 | -47.3% | 0.94% | -45.4% |
Q1 2016 | $13,383,000 | -33.7% | 2,212,036 | 0.0% | 1.71% | -14.4% |
Q4 2015 | $20,196,000 | +147.7% | 2,212,036 | +53.0% | 2.00% | +70.7% |
Q3 2015 | $8,152,000 | -89.8% | 1,445,430 | -80.0% | 1.17% | -85.5% |
Q2 2015 | $80,072,000 | -29.3% | 7,220,209 | 0.0% | 8.05% | -28.4% |
Q1 2015 | $113,213,000 | +2.8% | 7,220,209 | 0.0% | 11.24% | -5.1% |
Q4 2014 | $110,179,000 | +41.5% | 7,220,209 | 0.0% | 11.84% | +28.7% |
Q3 2014 | $77,870,000 | -42.0% | 7,220,209 | -17.9% | 9.20% | -32.2% |
Q2 2014 | $134,243,000 | -33.8% | 8,791,305 | -21.7% | 13.57% | -6.7% |
Q1 2014 | $202,895,000 | +77.5% | 11,222,053 | +36.4% | 14.55% | +9.3% |
Q4 2013 | $114,277,000 | +50.1% | 8,227,272 | +13.4% | 13.31% | +67.5% |
Q3 2013 | $76,139,000 | +16.5% | 7,258,244 | -13.3% | 7.95% | -8.3% |
Q2 2013 | $65,355,000 | – | 8,368,094 | – | 8.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |